Anna Minchom (@anna_minchom) 's Twitter Profile
Anna Minchom

@anna_minchom

Thoracic Medical Oncologist and early phase researcher

ID: 1501517890192871426

calendar_today09-03-2022 11:19:01

99 Tweet

208 Followers

191 Following

NCRI Partnership (@ncri_partners) 's Twitter Profile Photo

Last chance for NCRI #Lung_Group working group leaders! Applications for Chair & Deputy Chair for each new working and study group close on Sunday! See our newly-published strategy here and sign up to the network for further comms on membership 👉ow.ly/iIbN50NQ7nN

Last chance for NCRI #Lung_Group working group leaders! Applications for Chair & Deputy Chair for each new working and study group close on Sunday! 
See our newly-published strategy here and sign up to the network for further comms on membership
👉ow.ly/iIbN50NQ7nN
udaibanerji (@udai_banerji) 's Twitter Profile Photo

Professor Stan Kaye walking down memory lane, sharing anecdotes and words of wisdom. A giant in the world of medical oncology retired yesterday. We will miss him but his legacy of trainees across the world will continue the fight against cancer...The ICR The Royal Marsden NHS Foundation Trust

Professor Stan Kaye walking down memory lane, sharing anecdotes and words of wisdom. A giant in the world of medical oncology retired yesterday. We will miss him but his legacy of trainees across the world will continue the fight against cancer...<a href="/ICR_London/">The ICR</a>  <a href="/royalmarsdenNHS/">The Royal Marsden NHS Foundation Trust</a>
The ICR (@icr_london) 's Twitter Profile Photo

Importantly, through mentoring and training, Professor Stan Kaye, has played a major role in the careers of many clinicians and scientists around the world working in #CancerResearch.🌍 Find out more about Stan's incredible contributions to #Oncology 👇 icr.ac.uk/news-archive/p…

Importantly, through mentoring and training, Professor Stan Kaye, has played a major role in the careers of many clinicians and scientists around the world working in #CancerResearch.🌍

Find out more about Stan's incredible contributions to #Oncology 👇

icr.ac.uk/news-archive/p…
The ICR (@icr_london) 's Twitter Profile Photo

Today is #ClinicalTrialsDay! The ICR/The Royal Marsden NHS Foundation Trust' Drug Development Unit runs around 50 phase I trials at any one time, including trials of ICR-discovered drugs, developed by clinical academics, as well as drugs being developed with industry partners.

Today is #ClinicalTrialsDay!

The ICR/<a href="/royalmarsdenNHS/">The Royal Marsden NHS Foundation Trust</a>' Drug Development Unit runs around 50 phase I trials at any one time, including trials of ICR-discovered drugs, developed by clinical academics, as well as drugs being developed with industry partners.
Science and Innovation at Cancer Research UK (@crukresearch) 's Twitter Profile Photo

Have a look at Anna Minchom's, Johann de Bono's, Udai Banerji's & Juanita Lopez's poster on the CONSENT trial to improve #patient understanding of early phase clinical trials: bit.ly/3ONq9SM #CRUKFunded #ASCO23 The Royal Marsden NHS Foundation Trust The ICR

Hidehito HORINOUCHI (@hhorinouchi) 's Twitter Profile Photo

Abstract 9126: Subcutaneous amivantamab in patients with advanced solid tumors: The PALOMA study by Anna Minchom. IRRs were reported in 16% without grade 3 or more. PK analysis confirmed that ami SC 1600 mg Q2W shows similar exposure to the IV dose (1050 mg Q2W). #ASCO23 #LCSM

Abstract 9126: Subcutaneous amivantamab in patients with advanced solid tumors: The PALOMA study by <a href="/Anna_Minchom/">Anna Minchom</a>. IRRs were reported in 16% without grade 3 or more. PK analysis confirmed that ami SC 1600 mg Q2W shows similar exposure to the IV dose (1050 mg Q2W). #ASCO23 #LCSM
The Lancet Oncology (@thelancetoncol) 's Twitter Profile Photo

NEW: In the RAGNAR single-arm ph2 trial of erdafitinib in pts w/ adv solid tumours with FGFR alterations, an objective response was seen in 64 (30% [95% CI 24–36]) of 217 patients across 16 distinct tumour types (median FU 17·9 months [IQR 13·6–23·9]). thelancet.com/journals/lanon…

NEW: In the RAGNAR single-arm ph2 trial of erdafitinib in pts w/ adv solid tumours with FGFR alterations, an objective response was seen in 64 (30% [95% CI 24–36]) of 217 patients across 16 distinct tumour types (median FU 17·9 months [IQR 13·6–23·9]).

thelancet.com/journals/lanon…
Nicolò Battisti, MD (@nicolobattisti) 's Twitter Profile Photo

📢 Come and join us on 12 Sep 2023 for our The Royal Marsden NHS Foundation Trust Senior Adult Oncology study day to learn how a multidisciplinary approach improves the care of older adults with cancer The study day is endorsed by SIOG ➡️ Info & registration: tinyurl.com/2fvmdv7y #gerionc

📢 Come and join us on 12 Sep 2023 for our <a href="/royalmarsdenNHS/">The Royal Marsden NHS Foundation Trust</a> Senior Adult Oncology study day to learn how a multidisciplinary approach improves the care of older adults with cancer

The study day is endorsed by <a href="/SIOGorg/">SIOG</a> 

➡️ Info &amp; registration: tinyurl.com/2fvmdv7y

#gerionc
NHS Million (@nhsmillion) 's Twitter Profile Photo

If everyone who has been grateful for the NHS over the past 75 years followed and retweeted we’d reach a million by midnight Please take just two seconds to show you’re right behind NHS staff

If everyone who has been grateful for the NHS over the past 75 years followed and retweeted we’d reach a million by midnight

Please take just two seconds to show you’re right behind NHS staff
Christina Yap (@christinabyap) 's Twitter Profile Photo

Delighted to share PhD student Emily Alger's latest paper which: (i) Explores analysis of patient-reported outcomes (PROs) in dose-finding oncology trials, (ii) Uncovers methodological weaknesses, and (iii) Offers recommendations for PRO analysis tinyurl.com/ryy3m3p9

JessicaJLinMD (@jessicajlinmd) 's Twitter Profile Photo

Excited to share the first presentation of the preliminary activity and safety results on NVL-655, new ALK TKI. Brief recap here. Efficacy in heavily pretreated ALK+ NSCLC. Thanks to AACR #Targets23 for the opportunity to present, to collaborators, patients ALK Positive #LCSM

Excited to share the first presentation of the preliminary activity and safety results on NVL-655, new ALK TKI. Brief recap here. Efficacy in heavily pretreated ALK+ NSCLC. Thanks to <a href="/AACR/">AACR</a> #Targets23 for the opportunity to present, to collaborators, patients <a href="/ALKPositiveinc/">ALK Positive</a> #LCSM
BTOG (@btogorg) 's Twitter Profile Photo

Do you have a thoracic oncology study/trial idea and are you attending #BTOG24 ? Here's your chance to pitch your idea to expert researchers, a statistician and a professional lay advocate in our very own Dragons' Den style workshop! Apply here tinyurl.com/pr55f8wx

Do you have a thoracic oncology study/trial idea and are you attending #BTOG24 ?

Here's your chance to pitch your idea to expert researchers, a statistician and a professional lay advocate in our very own Dragons' Den style workshop!

Apply here tinyurl.com/pr55f8wx
BTOG (@btogorg) 's Twitter Profile Photo

#WCLCESMO24Update BTOG Webinar panel just announced: Tom Newsom-Davis (Chair) Martin Forster Yvonne Summers Meenali Chitnis btog.org/wclc-esmo-2024…

#WCLCESMO24Update BTOG Webinar panel just announced:

Tom Newsom-Davis (Chair)
Martin Forster
Yvonne Summers
Meenali Chitnis

btog.org/wclc-esmo-2024…
Adam Sharp (@adamsharpmedonc) 's Twitter Profile Photo

A wonderful bunch. My 6 months of SpR training in this unit was a wonderful experience. Must admit I had it easy…. Carbo/Pem…. Doce….. we have come so far and so much more to do. This greats are pushing boundaries on all fronts. Love em

BTOG (@btogorg) 's Twitter Profile Photo

The next session is titled, ‘Small Cell Lung Cancer: A New Awakening’ and is chaired by Star Wars fans Shobhit Baijal and Gerard Walls with Stephen Liu, Jarushka Naidoo and Anna Minchom speaking.  #BTOG25 The Force is strong with these ones …

The next session is titled, ‘Small Cell Lung Cancer: A New Awakening’ and is chaired by Star Wars fans Shobhit Baijal and Gerard Walls with Stephen Liu, Jarushka Naidoo and Anna Minchom speaking.  #BTOG25

The Force is strong with these ones …